Skip to contentZ
Zivo Bioscience, Inc.
Z
ZIVOZivo Bioscience, Inc. Q2 2017 · 10-Q
Revenue$0.00$0.00— vs Q2 2016 Net Income-$1.43M-$1.43MN/M vs Q2 2016 EPS Diluted-$0.01-$0.01N/M vs Q2 2016 Operating Income-$881,449N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
derived
ended Jun 30, 2017 · filed Aug 11, 2017 · 42 d after period end